Re: Additional Reports Of Exempt Distribution.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Reports Of Exempt Distribution.

in response to

Additional Reports Of Exempt Distribution.

KOO-KOO2

posted on Jun 20, 2024 12:47PM

Another Promissory Note: Dated 2024-06-11 for $ 344,175.00 US

With 250K warrants @ $0.83 US expire, 2029-06-11

Out of the USA.

Koo

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply